1 / 4

Healthcare Biomarkers Market is Expected to Grow US$ 56 Billion By 2022

The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecast period.

danishsmith01
Download Presentation

Healthcare Biomarkers Market is Expected to Grow US$ 56 Billion By 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthcare Biomarkers Market is Expected to Grow US$ 56 Billion By 2022 • New York, August 25, 2018: Market Research Engine has published a new report titled as “Healthcare Biomarkers Market By Product Analysis (Consumable, Software, Services); By Type Analysis (Safety biomarker, Validation biomarker, Efficacy biomarker); By Application Analysis (Diagnostics development, Personalized medicine, Drug discovery & development, Disease risk assessment); By Disease indication Analysis (Cancer, Neurological disorders, Cardiovascular disorders, Immunological disorders) and By Regional Analysis – Global Forecast by 2016- • 2022”. • A biomarker refers to a biological molecule or gene that is used to efficiently and correctly evaluate pharmacologic responses, pathogenic approaches, and biological tactics. Also known as a molecular marker or signature molecule, biomarkers are located in blood, different frame fluids, and tissue. Drastically used to peer the frame’s response to a selected remedy for a disease or condition, biomarkers assist clinical specialists to take powerful clinical decisions and help in diagnosing the fitness of patients. The U.S. food and drug management has approved the usage of biomarkers as surrogate quit-factors in the remedy improvement process. Biomarkers play a pivotal role in ailment danger assessment, drug discovery and improvement, diagnostics improvement, personalized medicinal drug, and others. Research activities are especially focused on the development of diagnostics biomarkers for mostcancers. • The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecastperiod. • You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/healthcare-biomarkers- market • The major driving factors of Global Healthcare Biomarkers Market are asfollows: • Rise in number of cros and low down cost for conduct clinical trials in developing nations. • Use of biomarkers in diagnostic procedure is enhancingrapidly. • Increasing healthcare expenses and R&Dfunding. • The restraining factors of Global Healthcare Biomarkers Market are asfollows: • Technological issue associated to sample andstorage. • High investment and low cost and benefitratio. • High testing cost • The Global Healthcare Biomarkers Market is segmented on the lines of its product, type, application, disease indication and regional. Based on product segmentation it covers consumable, software and services. Type segmentation covers safety biomarker,validation

  2. biomarker and efficacy biomarker. The applications segmentation contains diagnostics development, personalized medicine, drug discovery & development and disease risk assessment. Under disease indication segmentation it covers cancer, neurological disorders, cardiovascular disorders and immunological disorders. The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries. • This reportprovides: • An overview of the global market for Healthcare Biomarkers and relatedtechnologies. • Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2022. • Identifications of new market opportunities and targeted promotional plansfor • Healthcare Biomarkers. • Discussion of research and development, and the demand for new products and new applications. • Comprehensive company profiles of major players in theindustry. • REPORTSCOPE: • The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions. • The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. • The Global Healthcare Biomarkers Markethas been segmented asbelow: • By Product Analysis • Consumable • Software • Services • By TypeAnalysis • Safetybiomarker • Validation biomarker • Efficacybiomarker • By ApplicationAnalysis

  3. Diagnosticsdevelopment • Personalized medicine • Drug discovery &development • Disease riskassessment • By Disease indication Analysis • Cancer • Neurologicaldisorders • Cardiovasculardisorders • Immunologicaldisorders • By RegionalAnalysis • North America • Europe • Asia-Pacific • Rest of theWorld • Request SampleReport: • https://www.marketresearchengine.com/reportdetails/healthcare-biomarkers-market Table ofContents Introduction ResearchMethodology ExecutiveSummary PremiumInsights MarketOverview Biomarkers Market, By Product 7 Biomarkers Market, ByType Biomarkers Market, By Application Biomarkers Market, By Disease Indication 10 Biomarkers Market, ByRegion CompetitiveLandscape CompanyProfiles 12.1 QiagenN.V.

  4. Perkinelmer,Inc. • MerckMillipore • Bio-Rad Laboratories,Inc. • Enzo Biochem,Inc. • EKF Diagnostics Holdings,Inc. • Meso Scale Diagnostics,LLC. • Biosims TechnologiesSas • CisbioBioassays • Signosis, Inc. AboutMarketResearchEngine.com Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop businessstrategies. MediaContact Company Name: Market ResearchEngine Contact Person: John Bay Email:john@marketresearchengine.com Phone: +1-855-984-1862 Country: UnitedStates Website:https://www.marketresearchengine.com/

More Related